Abstract:Cytochrome P450 3A4 (CYP3A4), a key enzyme, is pivotal in metabolizing approximately half of the drugs used clinically. The genetic polymorphism of the CYP3A4 gene significantly influences individual variations in drug metabolism, potentially leading to severe adverse drug reactions (ADRs). In this study, we conducted a genetic analysis on CYP3A4 gene in 1163 Chinese Han individuals to identify the genetic variations that might affect their drug metabolism capabilities. For this purpose, a multiplex polymerase chain reaction (PCR) amplicon sequencing technique was developed, enabling us to perform the genotyping of CYP3A4 gene efficiently and economically on a large scale. As a result, a total of 14 CYP3A4 allelic variants were identified, comprising six previously reported alleles and eight new nonsynonymous variants that were nominated as new allelic variants *39–*46 by the PharmVar Association. Further, functional assessments of these novel CYP3A4 variants were undertaken by coexpressing them with cytochromes P450 oxidoreductase (CYPOR) in Saccharomyces cerevisiae microsomes. Immunoblot analysis indicated that with the exception of CYP3A4.40 and CYP3A4.45, the protein expression levels of most new variants were similar to that of the wild-type CYP3A4.1 in yeast cells. To evaluate their catalytic activities, midazolam was used as a probe drug. The results showed that variant CYP3A4.45 had almost no catalytic activity, whereas the other variants exhibited significantly reduced drug metabolism abilities. This suggests that the majority of the CYP3A4 variants identified in the Chinese population possess markedly altered capacities for drug metabolism. SIGNIFICANCE STATEMENT In this study, we established a multiplex polymerase chain reaction (PCR) amplicon sequencing method and detected the maximum number of new CYP3A4 variants in a single ethnic population. Additionally, we performed the functional characterizations of these eight novel CYP3A4 allele variants in vitro. This study not only contributes to the understanding of CYP3A4 genetic polymorphism in the Chinese Han population but also holds substantial reference value for their potential clinical applications in personalized medicine.

CYP17A1 Pathogenic Variants in 26 Chinese Patients With 17α-Hydroxylase Deficiency by Targeted Long-Read Sequencing

A Novel Compound Heterozygous CYP17A1 Variant Causes 17α-Hydroxylase/17, 20-Lyase Deficiency.

Rare hypertension as a result of 17alpha-hydroxylase deficiency.

Prevalence of CYP17A1 Gene Mutations in 17Α-Hydroxylase Deficiency in the Chinese Han Population

[Analysis of CYP17A1 Gene Variants in 5 Patients with 17-Hydroxylase Deficiency].

Identification of a Novel Mutation in CYP17A1 Gene

A3309 Clinical and Genetic Analysis of a Pedigree with Congenital Adrenal Hyperplasia (17Α-Hydroxylase /17,20-Lyase Deficiency) Literature

[Clinical and Molecular Genetic Analysis for 7 Patients from 5 Pedigrees with 17A-Hydroxylase/17, 20 Lyase Deficiency].

Identifying a novel mutation of CYP17A1 gene from five Chinese 17α-hydroxylase/17, 20-lyase deficiency patients.

Identification and Functional Assessment of EightCYP3A4Allelic Variants39–46Detected in the Chinese Han Population

New, Recurrent, and Prevalent Mutations: Clinical and Molecular Characterization of 26 Chinese Patients with 17Alpha-Hydroxylase/17,20-lyase Deficiency.

Clinical and Molecular Manifestation of Fifteen 17OHD Patients: a Novel Mutation and a Founder Effect

A novel homozygous mutation (TAC/AA) at codon 329 in CYP17A1 gene causes 17α-hydroxylase deficiency--case report and pedigree study

Phenotype-genotype Correlation in Eight Chinese 17Alpha-Hydroxylase/17,20 Lyase-Deficiency Patients with Five Novel Mutations of CYP17A1 Gene.

[A Clinical and Genetic Analysis of a Pedigree with Two 46,XY Patients Suffering from 17Alpha-Hydroxylase Deficiency].

Identification of Novel and Rare CYP21A2 Variants in Chinese Patients with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency.

A Unique Exonic Splicing Mutation in the CYP17A1 Gene as Cause of Steroid 17 alpha-Hydroxylase Deficiency.

[Genetic Mutation Analysis of a Kindred with a Patient Suffering from 17 Alpha-Hydroxylase/17, 20-Lyase Deficiency].

Clinical and Genetic Analysis for Two Chinese Siblings with 17Α-Hydroxylase/17,20-lyase Deficiency

Clinical and Genetic Analysis for 10 Patients with 17α Hydroxylase/17,20 Lyase Deficiency

Identification of Steroid Biosynthetic Defects in Genotype‐proven Heterozygous Individuals for 17α‐hydroxylase/17,20‐lyase Deficiency